» Articles » PMID: 9525994

Fibronectin and Alpha5 Integrin Regulate Keratinocyte Cell Cycling. A Mechanism for Increased Fibronectin Potentiation of T Cell Lymphokine-driven Keratinocyte Hyperproliferation in Psoriasis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1998 Apr 29
PMID 9525994
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In addition to being T lymphocyte-driven, psoriasis may be due in part to abnormal integrin expression. Normal-appearing (uninvolved) skin from psoriatic patients was examined to determine whether altered fibronectin or its receptor expression is detectable before development of psoriatic lesions. In contrast to skin from normal subjects, we detect by immunofluorescence the abnormal presence of plasma fibronectin in the basal cell layer of the epidermis of psoriatic uninvolved skin. Furthermore, increased fibronectin exposure superinduces the in vitro cell cycle induction and expansion of psoriatic nonlesional keratinocytes in response to a cocktail of T cell lymphokines. Fibronectin alone also appeared to increase cell cycle entry among uninvolved but not normal keratinocytes. Concordantly, the alpha5 integrin fibronectin receptor, but not alpha2 or alpha3, is overexpressed in the in vivo nonlesional psoriatic epidermis. The involvement of alpha5beta1 in the early outgrowth of clonogenic keratinocytes in the ex vivo culture was demonstrated by the ability of anti-alpha5 mAb to inhibit keratinocyte growth on fibronectin. Thus, the fibronectin receptor appears to be one of the components required for the development of the hyperresponsiveness of psoriatic keratinocytes to signals for proliferation provided by lymphokines produced by intralesional T lymphocytes in psoriasis.

Citing Articles

Integrins as a bridge between bacteria and cells: key targets for therapeutic wound healing.

Yu D, Lu Z, Chong Y Burns Trauma. 2024; 12:tkae022.

PMID: 39015251 PMC: 11250365. DOI: 10.1093/burnst/tkae022.


A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis.

Coto-Segura P, Segu-Verges C, Martorell A, Moreno-Ramirez D, Jorba G, Junet V Front Immunol. 2023; 14:1212981.

PMID: 37809085 PMC: 10552644. DOI: 10.3389/fimmu.2023.1212981.


Abnormal basement membrane results in increased keratinocyte-derived periostin expression in psoriasis similar to wound healing.

Flink L, Ghaffarinia A, Papp B, Varga A, Vigh A, Vidacs D Sci Rep. 2023; 13(1):16386.

PMID: 37773198 PMC: 10541889. DOI: 10.1038/s41598-023-43396-0.


Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesis.

Lian N, Chen Y, Chen S, Zhang Y, Chen H, Yang Y Cell Death Dis. 2023; 14(9):595.

PMID: 37673869 PMC: 10482869. DOI: 10.1038/s41419-023-06094-3.


Mechanotransduction in Skin Inflammation.

Shutova M, Boehncke W Cells. 2022; 11(13).

PMID: 35805110 PMC: 9265324. DOI: 10.3390/cells11132026.


References
1.
Baadsgaard O, Tong P, Elder J, HANSEN E, Ho V, Hammerberg C . UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions. J Invest Dermatol. 1990; 95(3):275-82. DOI: 10.1111/1523-1747.ep12484908. View

2.
Javier A, Bata-Csorgo Z, Ellis C, Kang S, Voorhees J, Cooper K . Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells. J Clin Invest. 1997; 99(9):2094-9. PMC: 508039. DOI: 10.1172/JCI119382. View

3.
Lortat-Jacob H, Kleinman H, Grimaud J . High-affinity binding of interferon-gamma to a basement membrane complex (matrigel). J Clin Invest. 1991; 87(3):878-83. PMC: 329877. DOI: 10.1172/JCI115093. View

4.
Schwartz M, Lechene C, Ingber D . Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin alpha 5 beta 1, independent of cell shape. Proc Natl Acad Sci U S A. 1991; 88(17):7849-53. PMC: 52401. DOI: 10.1073/pnas.88.17.7849. View

5.
Toda K, Tuan T, Brown P, Grinnell F . Fibronectin receptors of human keratinocytes and their expression during cell culture. J Cell Biol. 1987; 105(6 Pt 2):3097-104. PMC: 2114680. DOI: 10.1083/jcb.105.6.3097. View